Eikon Therapeutics, Inc. · NASDAQ:EIKN
BlackRock Portfolio Management LLC reported a 5.50% stake in Eikon Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
BlackRock Portfolio Management LLC reported a 5.50% stake in Eikon Therapeutics, Inc., 3,002,737 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 3,002,737
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 5.50% | 3,002,737 |
Source
Related
- Eikon Therapeutics, Inc.
- BlackRock Portfolio Management LLC
- Eikon Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G/A · Abu Dhabi Investment Authority · Oct 2, 2026
- Form 4 · Kutzkey Tim · Sep 8, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Innovation Endeavors III LP · May 15, 2026